You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
榮昌生物-B(09995.HK)開立理財產品專用結算賬户

榮昌生物-B(09995.HK)公吿,榮昌生物製藥(煙台)股份有限公司(以下簡稱“公司”)於2022年4月16日召開了第一屆董事會第十九次會議和第一屆監事會第六次會議,審議通過了《關於使用閒置募集資金購買理財產品的議案》,同意公司使用不超過人民幣7億元的閒置募集資金購買安全性高、流動性好、購買機構不限於銀行、證券等金融機構的理財產品進行委託理財。

公司開立了募集資金理財產品專用結算賬户,根據《上市公司監管指引第2號——上市公司募集資金管理和使用的監管要求》、《上海證券交易所科創板上市公司自律監管指引第1號——規範運作》的相關規定,公司將在理財產品到期且無下一步購買計劃時及時註銷以上專户。上述產品專用結算賬户將專用於暫時閒置募集資金購買理財產品的結算,不會用於存放非募集資金或用作其他用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account